DEA schedule
Is methylphenidate a controlled substance?
Federal schedule for methylphenidate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Methylphenidate is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted methylphenidate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 245 prescription listings from 46 labelers, all Schedule II |
| DEA controlled substances list | Methylphenidate: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Methylphenidate | 1724 | II | No | Concerta; Ritalin; Methylin | Listed by name |
Methylphenidate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50458-585 | CONCERTA | tablet, extended release | 18 mg/1 | Janssen Pharmaceuticals, Inc. | CII |
| 50458-588 | CONCERTA | tablet, extended release | 27 mg/1 | Janssen Pharmaceuticals, Inc. | CII |
| 50458-586 | CONCERTA | tablet, extended release | 36 mg/1 | Janssen Pharmaceuticals, Inc. | CII |
| 50458-587 | CONCERTA | tablet, extended release | 54 mg/1 | Janssen Pharmaceuticals, Inc. | CII |
| 70165-200 | Cotempla XR-ODT | tablet, orally disintegrating | 17.3 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-300 | Cotempla XR-ODT | tablet, orally disintegrating | 25.9 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-100 | Cotempla XR-ODT | tablet, orally disintegrating | 8.6 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 68968-5552 | Daytrana | patch | 10 mg/9h | Noven Therapeutics, LLC | CII |
| 68968-5553 | Daytrana | patch | 15 mg/9h | Noven Therapeutics, LLC | CII |
| 68968-5554 | Daytrana | patch | 20 mg/9h | Noven Therapeutics, LLC | CII |
| 68968-5555 | Daytrana | patch | 30 mg/9h | Noven Therapeutics, LLC | CII |
| 71376-205 | JORNAY PM Extended-Release | capsule | 100 mg/1 | Ironshore Pharmaceuticals Inc. | CII |
| 71376-201 | JORNAY PM Extended-Release | capsule | 20 mg/1 | Ironshore Pharmaceuticals Inc. | CII |
| 71376-202 | JORNAY PM Extended-Release | capsule | 40 mg/1 | Ironshore Pharmaceuticals Inc. | CII |
| 71376-203 | JORNAY PM Extended-Release | capsule | 60 mg/1 | Ironshore Pharmaceuticals Inc. | CII |
| 71376-204 | JORNAY PM Extended-Release | capsule | 80 mg/1 | Ironshore Pharmaceuticals Inc. | CII |
| 0527-6579 | METADATE CD | capsule, extended release | 10 mg/1 | Lannett Company, LLC | CII |
| 69654-579 | METADATE CD | capsule, extended release | 10 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6580 | METADATE CD | capsule, extended release | 20 mg/1 | Lannett Company, LLC | CII |
| 69654-580 | METADATE CD | capsule, extended release | 20 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6581 | METADATE CD | capsule, extended release | 30 mg/1 | Lannett Company, LLC | CII |
| 69654-581 | METADATE CD | capsule, extended release | 30 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6582 | METADATE CD | capsule, extended release | 40 mg/1 | Lannett Company, LLC | CII |
| 69654-582 | METADATE CD | capsule, extended release | 40 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6583 | METADATE CD | capsule, extended release | 50 mg/1 | Lannett Company, LLC | CII |
| 69654-583 | METADATE CD | capsule, extended release | 50 mg/1 | Aytu BioPharma, Inc. | CII |
| 0527-6584 | METADATE CD | capsule, extended release | 60 mg/1 | Lannett Company, LLC | CII |
| 69654-584 | METADATE CD | capsule, extended release | 60 mg/1 | Aytu BioPharma, Inc. | CII |
| 59630-755 | Methylin | solution | 10 mg/5mL | SHIONOGI INC. | CII |
| 59630-750 | Methylin | solution | 5 mg/5mL | SHIONOGI INC. | CII |
| 24478-074 | QuilliChew ER | tablet, chewable, extended release | 20 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 24478-075 | QuilliChew ER | tablet, chewable, extended release | 30 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 24478-076 | QuilliChew ER | tablet, chewable, extended release | 40 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 24478-321 | Quillivant XR | suspension, extended release | 300 mg/60mL | NextWave Pharmaceuticals, Inc | CII |
| 24478-322 | Quillivant XR | suspension, extended release | 600 mg/120mL | NextWave Pharmaceuticals, Inc | CII |
| 24478-323 | Quillivant XR | suspension, extended release | 750 mg/150mL | NextWave Pharmaceuticals, Inc | CII |
| 24478-324 | Quillivant XR | suspension, extended release | 900 mg/180mL | NextWave Pharmaceuticals, Inc | CII |
| 68025-095 | RELEXXII | tablet, extended release | 18 mg/1 | Vertical Pharmaceuticals, LLC | CII |
| 68025-096 | RELEXXII | tablet, extended release | 27 mg/1 | Vertical Pharmaceuticals, LLC | CII |
| 68025-097 | RELEXXII | tablet, extended release | 36 mg/1 | Vertical Pharmaceuticals, LLC | CII |
Showing 40 of 245 listings.
Questions
Is methylphenidate a controlled substance?
Yes. Methylphenidate is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Is methylphenidate a narcotic?
No. The DEA list does not mark methylphenidate as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is methylphenidate?
Methylphenidate is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Methylphenidate
- What is Methylphenidate used for?FDA label uses
- Generic for Aptensio XRFDA Orange Book
- Generic for Jornay PMFDA Orange Book
- Generic for Metadate CDFDA Orange Book
- Generic for Ritalin LAFDA Orange Book
- Generic for DaytranaFDA Orange Book
- Generic for Quillivant XRFDA Orange Book
- Generic for MethylinFDA Orange Book
- Generic for QuilliChew ERFDA Orange Book
- Generic for ConcertaFDA Orange Book
- Generic for RelexxiiFDA Orange Book
- Generic for Ritalin-srFDA Orange Book
- Generic for Cotempla XR-ODTFDA Orange Book
- What is Concerta used for?FDA label uses
- Is Concerta a controlled substance?Schedule II
- What is Ritalin used for?FDA label uses